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Background: Serum lipids and the ratios are known to be associated with the cardiovascular diseases (CVD).
However, the associations of serum lipids and the ratios related to arterial stiffness are unclear. We sought to
compare the strength of these serum lipids and the ratios with arterial stiffness assessing by brachial-ankle pulse
wave velocity (baPWV) in the middle-aged and elderly Chinese subjects.
Methods: A total number of 1133 Chinese aged from 50 to 90 years old were recruited from Shanghai downtown
district. The serum lipids, baPWV and major cardiovascular risk factors of the participants were measured.
Results: Participants with high baPWV exhibited higher levels of non-HDL-c, TC/HDL-c, TG/HDL-c, LDL-c/HDL-c, and
non-HDL-c/HDL-c, while HDL-c worked in the opposite direction (all P<0.05). In addition, TC, TG, LDL-c, non-HDL-c,
TC/HDL-c, TG/HDL-c, LDL-c/HDL-c, and non-HDL-c/HDL-c had a positive relationship with the baPWV value, while
HDL-c was on the contrary (all P <0.05). Finally, individuals with high non-HDL-c/HDL-c (OR 1.71, 95% CI 1.06-2.55,
P = 0.013) and low HDL-c (OR 0.57, 95% CI 0.35-0.96, P = 0.024) were seem to be at high risk of arterial stiffness.
Conclusions: As a risk indicator, non-HDL-c/HDL-c, which could be readily obtained from routine serum lipids, was
significantly associated with baPWV. Non-HDL-c/HDL-c was superior to traditional lipid variables for estimating
arterial stiffness in the middle-aged and elderly Chinese population.
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As cardiovascular diseases (CVD) have been the leading
cause of death worldwide, the identification of cardiovas-
cular risk factors at an early stage of life has become
more and more popular. Some fixed factors (age, sex,
and family history) and a number of modifiable factors
(hyperlipidemia, smoking, hypertension, hyperglycemia,
etc.) had been emerging for predicting CVD [1].
Dyslipidemia is characterized with elevated total choles-
terol (TC), triglyceride (TG), and low-density lipoprotein
cholesterol (LDL-c) as well as decreased high-density lipo-
protein cholesterol (HDL-c) concentrations. The serum* Correspondence: yangyehongfd@163.com; renminghu@fudan.edu.cn
†Equal contributors
1Department of Endocrinology and Metabolism, Huashan Hospital, Fudan
University, Shanghai, China
Full list of author information is available at the end of the article
© 2014 Zhao et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.lipid abnormalities are recognized as independent ap-
proximate risks for CVD. Many investigations had dem-
onstrated the relationships between TC, TG, HDL-c,
LDL-c and CVD [2-5]. Arterial stiffness measured by
brachial-ankle pulse wave velocity (baPWV) is known to
be a marker of subclinical atherosclerosis and serves as an
independent risk predictor for CVD [6]. The identification
of arterial stiffness in these high risk individuals before the
development of clinical atherosclerosis would be of sub-
stantial clinical benefit.
We had identified serum HDL-c that had protective
effect on arterial stiffness in middle aged and elderly
Chinese [7]. Several other cross-sectional studies had
also evaluated the strength of the relationships between
arterial stiffness and single proatherogenic lipid or ratio,
such as the LDL-c, non-HDL-c, and TG/HDL-c. How-
ever, the superiority of the lipid parameters was nottd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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[8-10]. In one Chinese study, LDL-c was found independ-
ently associated with aortic stiffness [8]. Furthermore, a
Netherlandish study supported the use of non-HDL-c as a
superior predictor to LDL-c in identifying individuals for
arterial stiffness [9]. An American study showed that
TG/HDL-c was an independent determinant of arterial
stiffness in adolescents and young adults [10]. On
these premises, it prompted us to perform the present
study to directly compare the association of these
serum lipids to the ratios (including TC, TG, HDL-c,
LDL-c, non-HDL-c, TC/HDL-c, TG/HDL-c, LDL-c/
HDL-c, and non-HDL-c/HDL-c) with arterial stiffness
assessing by baPWV in the middle-aged and elderly




From September 2007 to August 2008, a large-scale local
health-check program was launched by Huashan Hos-
pital in Shanghai, China. All studied individuals came
from the Jiangninglu community of the Jingan District
and the Youyilu community of the Baoshan District in
Shanghai. A multistage stratified cluster sampling method
was carried out to select subjects from the two communi-
ties. We selected the units in neighborhood. Only partici-
pants aged over 50 years old were recruited from each
household. All studied individuals were of southern Han
Chinese. A total of 1492 eligible subjects participated in
the study, 359 of them were excluded from the analysis
for the usage of hypolipidemic agents or missing data.
Written informed consents were obtained from all partici-
pants and the study was approved by the Institutional Re-
view Board of Huashan Hospital.
Participants with the following conditions were ex-
cluded: nutritional derangements; anaemia; malignancy;
thyroid dysfunction; pregnancy; breast-feeding; mental
illness.
Data collection
The methodology used to obtain data of clinical and bio-
chemical variables had been previously published [7]. In
brief, a standardized questionnaire was performed by
qualified internist to collect information such as age,
gender, smoking, self-reported dyslipidemia, hyperten-
sion, and CVD.
All subjects were assessed after overnight fasting for at
least 10 hours. The details of anthropometric measure-
ments include height, weight, waist circumference, hip
circumference, and blood pressure were carried by
trained physicians using standard methods. Body mass
index (BMI) was calculated as weight in kilograms di-
vided by the square of height in meters.Laboratory measurements
The measurements of fasting plasma glucose and
hemoglobin A1c, fasting serum insulin, TC, TG, HDL-c,
LDL-c, creatinine, uric acid, and white blood cell counts
were performed in the centralized laboratory of Huashan
Hospital [7,11]. Non-HDL-c was calculated by subtracting
HDL-c from TC. Insulin resistance was estimated by
homeostasis model assessment index-insulin resistance
(HOMA-IR) [12]. Glomerular filtration rate (GFR;
expressed in ml/min/1.73 m2) was calculated by CKD-
EPI equation [13].
Hypertension was defined as if blood pressure 140/
90 mmHg or greater or current use of antihypertensive
drugs [14]. Metabolic syndrome (Mets) was defined
based on the updated International Diabetes Federation
(IDF) criteria for Asian-American [15].
Measurements of baPWV
BaPWV was measured by the VP-1000 Automatic Ar-
teriosclerosis Measurement System (model BP-203
RPE-II, Colin Co, Ltd, Komaki, Japan). The details of
the measurement, validity, and reproducibility have
been reported previously [16,17]. The correlation coef-
ficients of interobserver and intraobserver reproduci-
bility were 0.98 and 0.87, respectively. The device can
record pulse waves in four cuffs, record the transmis-
sion time to arm and ankles, calculate the transmission
distance from the right arm to each ankle according to
body height, and automatically compute the baPWV
values by transmission time and distance. Measure-
ments were taken after the subject had a 5 min rest in
a supine position at room temperature. Participants
were advised to refrain from smoking, alcohol, caffein-
ated beverages and vigorous exercise for over 2 hours
prior to the examination. The relationship between left
and right baPWV was pretty high (r = 0.955, P < 0.001)
[7]. As a result, we used the mean of bilateral baPWV
value during analysis.
Statistical analysis
All statistical analysis was performed using SPSS version
16.0 (SPSS, Chicago, IL, USA). Continuous variables
were expressed as means ± SD or median (interquartile
range). Categorical variables were represented by fre-
quency and percentage. The characteristics of the study
population and lipid parameters according to baPWV
tertiles were compared by ANOVA for continuous vari-
ables and chi-squared test for categorical variables.
Correlation coefficients between lipid parameters and
baPWV were calculated by partial correlation analysis. The
odds ratios for high baPWV (defined as baPWV >75th per-
centile) [7,18] were calculated by a multivariate logistic re-
gression analysis in different lipid parameters. We stratified
the lipids and the ratios into tertiles and estimated the odds
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tiles by using the first tertile as reference.
Results
General characteristics of the study participants
1133 participants were analyzed, among which 38.0%
(430/1133) were men, 62.0% (703/1133) were women.
Table 1 compared the demographic, anthropometric,
and biochemical characteristics of the experimental
population, which was divided into different gender
subgroups. The levels of age, waist to hip ratio, diastolic
blood pressure, TC/HDL-c, LDL-c/HDL-c, nonHDL-c/Table 1 Characteristics of participants categorized by gender
classification
Total Male Female P
Number 1133 430 703
Age (years) 64.0 ± 8.6 65.4 ± 8.7 63.1 ± 8.4 <0.001
Smoking (%) 246(21.7) 136(31.6) 110(15.6) <0.001
Self-reported
CVD (%)
239(21.1) 83(19.3) 156(22.2) 0.279
Waist to hip ratio 0.88 ± 0.06 0.91 ± 0.06 0.86 ± 0.06 <0.001
Body mass
index (kg/m2)
25.4 ± 3.3 25.2 ± 3.2 25.5 ± 3.3 0.278
SBP (mmHg) 138.7 ± 19.2 139.0 ± 18.8 138.5 ± 19.4 0.630
DBP (mmHg) 83.8 ± 10.6 85.0 ± 10.1 83.0 ± 10.8 0.002
Hypertension (%) 809(71.4) 317(73.7) 492(70.0) 0.200
TC 5.34 ± 1.00 5.08 ± 0.91 5.50 ± 1.03 <0.001
TG 1.61(1.09-2.30) 1.55(1.06-2.20) 1.65(1.10-2.38) 0.154
HDL 1.29 ± 0.32 1.21 ± 0.31 1.34 ± 0.32 <0.001
LDL 3.02 ± 0.78 2.91 ± 0.73 3.09 ± 0.80 0.001
nonHDL 4.04 ± 0.97 3.87 ± 0.91 4.15 ± 0.99 <0.001
TC/HDL 4.32 ± 1.11 4.41 ± 1.14 4.27 ± 1.09 0.043
TG/HDL 1.29(0.80-2.05) 1.36(0.86-2.11) 1.27(0.77-1.98) 0.613
LDL/HDL 2.44 ± 0.79 2.53 ± 0.84 2.39 ± 076 0.005
nonHDL/HDL 3.32 ± 1.11 3.41 ± 1.14 3.27 ± 1.09 0.044
FPG (mmol/l) 6.9 ± 2.3 6.9 ± 2.5 6.8 ± 2.1 0.508
HbA1C 6.6 ± 1.3 6.8 ± 1.5 6.5 ± 1.2 0.021
HOMA-IR 3.37(2.12-5.56) 3.33(2.13-5.92) 340(2.10-5.44) 0.637
GFR (ml/min/1.732) 92.2 ± 13.7 89.5 ± 14.5 93.9 ± 13.0 <0.001
BaPWV (cm/s) 1745 ± 364 1782 ± 364 1723 ± 362 0.040
MetS (%) 759(67.0) 247(57.4) 512(72.8) <0.001
White blood
cell (109/l)
6.1 ± 1.6 6.4 ± 1.7 5.9 ± 1.4 <0.001
Serum creatinine
(μmol/l)
64.3 ± 18.7 76.4 ± 21.7 56.9 ± 11.4 <0.001
Uric acid (μmol/l) 315(260–370) 345(290–400) 300(251–347) 0.007
CVD, cardiovascular disease; SBP, systolic blood pressure; DBP, diastolic blood
pressure; FPG, fasting plasma glucose; HOMA-IR, homeostasis model assessment
index-insulin resistance; GFR, glomerlar filtration rate; BaPWV, brachial-ankle pulse
wave velocity; MetS, metabolic syndrome.
Data were reported in mean ± SD, median (interquartile range), or number (percent).HDL-c, HbA1C, white blood cell, serum creatinine, uric
acid, and the percentage of smoking were significantly
higher in men than in women. The levels of TC, HDL-c,
LDL-c, nonHDL-c, GFR, baPWV, and the state of MetS
were significantly lower in men than in women (all P <0.05).
The level of body mass index, systolic blood pressure, TG,
TG/HDL-c, and the percentage of self-reported CVD, the
state of hypertension were similar in both genders.
Lipid profiles distribution according to baPWV tertiles
The participants were divided into tertiles on the basis
of the levels of baPWV. The lipid profiles and the ratios
distribution of the participants differing by baPWV
tertiles were performed in Table 2. In the overall and
female population, participants with high baPWV ex-
hibited higher levels of non-HDL-c, TC/HDL-c, TG/
HDL-c, LDL-c/HDL-c, and non-HDL-c/HDL-c, while
HDL-c worked in the opposite direction (P<0.05).
However, in men, only the levels of TC/HDL-c and non-
HDL-c/HDL-c increased with the level of baPWV, and
HDL-c decreased with the level of baPWV (P<0.05).
The relationships between baPWV and lipid profiles
As some lipid parameters were differently distributed in
men and women, we investigated the relationships of
serum lipids and lipid ratios with baPWV in men and
woman separately. As shown in Table 3, baPWV was
significantly associated with TC, TG, HDL-c, LDL-c,
non-HDL-c, TC/HDL-c, TG/HDL-c, LDL-c/HDL-c, and
non-HDL-c/HDL-c in both genders. The highest correl-
ation coefficient reached 0.180 in non-HDL-c/HDL-c.
However, the correlationship of TC and TG with baPWV
disappeared in male, while the correlationship of TC and
LDL-c with baPWV disappeared in female.
Remarkably, as presented in the multivariate logistic
regression analysis, the ORs for probability of being ar-
terial stiffness were increased along non-HDL-c/HDL-c
(OR 1.71, 95% CI 1.06-2.55, P = 0.013) tertiles after adjust-
ing for age and sex, and decreased along HDL-c (OR 0.57,
95% CI 0.35-0.96, P = 0.024) tertiles (Table 4). However,
the ORs of TC, TG, LDL-c, non-HDL-c, TC/HDL-c,
TG/HDL-c, and LDL-c/HDL-c did not reach statistical
significance.
Discussion
The study was conducted in a population of middle-
aged and elderly Chinese, which was known to have a
high prevalence of arterial stiffness. In previous study,
we concluded that serum HDL-c had protective effect
on arterial stiffness. As an extension of previous study,
we investigated the clinical evaluation of the various
lipid ratio profiles and had two major findings: 1) all
the lipid profiles and lipid ratios, such as TC, TG,
HDL-c, LDL-c, non-HDL-c, TC/HDL-c, LDL-c/HDL-c,
Table 2 Serum lipids and their ratios distribution according to baPWV tertiles
T1 T2 T3 P
TC Overall 5.29 ± 0.91 5.40 ± 0.98 5.34 ± 1.07) 0.478
(mmol/L) M 5.06 ± 0.79 5.12 ± 0.86 5.05 ± 0.95 0.597
F 5.41 ± 0.94 5.55 ± 1.01 5.57 ± 1.12 0.307
TG Overall 1.51(1.01-2.17) 1.69(1.03-2.37) 1.58(1.11-2.47) 0.045
(mmol/L) M 1.44(0.99-2.04) 1.56(1.01-2.18) 1.54(1.03-2.24) 0.585
F 1.51(1.01-2.21) 1.77(1.04-2.47) 1.65(1.23-2.66) 0.014
HDL-c Overall 1.36 ± 0.33 1.29 ± 0.30 1.24 ± 0.29 <0.001
(mmol/L) M 1.30 ± 0.39 1.26 ± 0.31 1.15 ± 0.24 0.019
F 1.39 ± 0.30 1.31 ± 0.29 1.30 ± 0.31 0.009
LDL-c Overall 2.98 ± 0.72 3.06 ± 0.79 2.98 ± 0.76 0.36
(mmol/L) M 2.84 ± 0.66 2.92 ± 0.73 2.88 ± 0.73 0.648
F 3.05 ± 0.74 3.14 ± 0.82 3.06 ± 0.77 0.442
nonHDL-c Overall 3.92 ± 0.89 4.11 ± 0.97 4.11 ± 1.03 0.043
(mmol/L) M 3.75 ± 0.79 3.86 ± 0.92 3.90 ± 0.94 0.512
F 4.00 ± 0.93 4.25 ± 0.97 4.27 ± 1.07 0.03
TC/HDL-c Overall 4.05 ± 0.99 4.35 ± 1.07 4.49 ± 1.15 <0.001
M 4.14 ± 1.05 4.29 ± 1.18 4.56 ± 1.14 0.032
F 4.01 ± 0.96 4.39 ± 1.02 4.44 ± 1.17 <0.001
TG/HDL-c Overall 1.09(0.68-1.89) 1.35(0.77-2.03) 1.37(0.86-2.19) 0.003
M 1.21(0.74-2.08) 1.33(0.77-1.95) 1.40(0.84-2.24) 0.187
F 1.07(0.63-1.83) 1.38(0.78-2.08) 1.33(0.86-2.17) 0.005
LDL-c/HDL-c Overall 2.29 ± 0.74 2.47 ± 0.78 2.50 ± 0.75 0.004
M 2.35 ± 0.78 2.48 ± 0.90 2.58 ± 0.78 0.158
F 2.26 ± 0.71 2.47 ± 0.71 2.44 ± 0.72 0.012
nonHDL-c/HDL-c Overall 3.04 ± 0.98 3.40 ± 1.07 3.50 ± 1.15 <0.001
M 3.13 ± 1.05 3.28 ± 1.18 3.56 ± 1.14 0.027
F 3.00 ± 0.95 3.39 ± 1.02 3.45 ± 1.16 <0.001
TC, total cholesterol; TG, triglyceride; HDL-c, high-density lipoprotein cholesterol.
LDL-c, low-density lipoprotein cholesterol; baPWV, brachial-ankle pulse wave velocity; T, tertile; M, male; F, female.
Table 3 Correlation between baPWV and lipid parameters
Variable Overallb Malec Femalec
TC 0.074a 0.094 0.062
TG 0.124a 0.102 0.132a
HDL-c −0.143a −0.140a −0.162a
LDL-c 0.075a 0.124a 0.047
nonHDL-c 0.125a 0.171a 0.096a
TC/HDL-c 0.177a 0.231a 0.130a
TG/HDL-c 0.136a 0.133a 0.133a
LDL-c/HDL-c 0.154a 0.217a 0.106a
Non-HDL-c/HDL-c 0.180a 0.240a 0.135a
TC, total cholesterol; TG, triglyceride; HDL-c, high-density
lipoprotein cholesterol.
LDL-c, low-density lipoprotein cholesterol; BaPWV, brachial-ankle pulse
wave velocity.
aP < 0.05.
bCorrelation coefficients were calculated after adjusted for age and gender.
cCorrelation coefficientswere calculated after adjusted for age.
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with arterial stiffness assessing by baPWV, and 2) Individ-
uals with higher non-HDL-c/HDL-c levels have higher
risk of arterial stiffness than other lipid parameters.
CVD represents a major cause of morbidity and mor-
tality worldwide [1]. Arterial stiffness is an important de-
terminant of cardiovascular risk [19,20]. Patients with
hypercholesterolaemia have higher stiff blood vessels
than matched controls, which have similar peripheral
blood pressures [21]. Earlier studies had indicated that
lipids and the related ratios were strong predictors of
CVD. Some lipids had been the main target for clinical
intervention of CVD [22-25]. Most previous studies fo-
cused on only one ratio or traditional lipids [8-10].
There is no study that evaluated the relationship be-
tween all the lipids and lipid ratios with arterial stiffness.
In the present study, we evaluated the relationship be-
tween the lipids and the ratios with baPWV, and
Table 4 Age and sex-adjusted odds ratios (95% confidence intervals) for high baPWV by tertiles of lipid profiles
Tertiles Odds Ratio (95% confidence interval)
Age and sex-adjusted
TC TG HDL-c LDL-c Non-HDL-c
I 1 1 1 1 1
II 1.12(0.71-1.75) 1.27(0.81-1.99) 0.71(0.46-1.08) 1.12(0.70-1.77) 1.12(0.72-1.74)
III 1.27(0.85-1.92) 1.38(0.91-2.11) 0.57(0.35-0.96) 1.40(0.90-2.16) 1.27(0.84-2.04)
P 0.501 0.185 0.024 0.104 0.394
TC/HDL-c TG/HDL-c LDL-c/HDL-c Non-HDL-c/HDL-c
I 1 1 1 1
II 1.07(0.68-1.69) 1.16(0.74-1.83) 1.44(0.92-2.26) 1.08(0.75-1.67)
III 1.56(1.00-2.43) 1.52(0.97-2.37) 1.52(0.96-2.40) 1.71(1.06-2.55)
P 0.050 0.069 0.075 0.013
TC, total cholesterol; TG, triglyceride; HDL-c, high-density lipoprotein cholesterol.
LDL-c, low-density lipoprotein cholesterol; BaPWV, brachial-ankle pulse wave velocity.
Zhao et al. Lipids in Health and Disease 2014, 13:37 Page 5 of 6
http://www.lipidworld.com/content/13/1/37highlighted the rationale for using the lipid ratio of non-
HDL-c/HDL-c as a risk factor for arterial stiffness risk in
middle-aged and elderly Chinese.
In the study, HDL-c and all the lipid ratios were sig-
nificantly correlated with the baPWV tertiles in the over-
all patients. Only HDL-c, TC/HDL-c, and non-HDL-c/
HDL-c worked in both the male and female population.
All the conventional lipids and the ratios had a signifi-
cant correlation with baPWV in the overall population.
Only HDL-c and the lipid ratios worked in both the
male and female population. Finally, in the multivariate
logistic regression analysis after adjusting for age and
gender, only non-HDL-c/HDL-c and HDL-c had signifi-
cant estimating capacities. Non-HDL-c/LDL-c seemed
to be superior to HDL-c in assessing the risk for arterial
stiffness. Non-HDL-c/HDL-c, an easily obtained index,
maybe offer convenience in screening large populations
of arterial stiffness risk in routine clinical practice.
The pathophysiology of non-HDL-c/HDL-c with arter-
ial stiffness is unclear, but data from literatures is help-
ful. Non-HDL-c is a measurement of the cholesterol in
LDL and VLDL (intermediate-density lipoprotein and
very-LDL) particles. In clinical practice, non-HDL-c had
been recommended as a secondary therapeutic target in
individuals with high TG concentration. It also had been
reported to be a better predictor of CVD than LDL-c
[26]. The non-HDL-c/HDL-c is a lineal combination of
TG and HDL-c. In the last few years, the focus had been
shifted towards non-HDL-c/HDL-c. A report from the
Swedish National Diabetes Register demonstrated that
non-HDL-c/HDL-c had a stronger relationship with cor-
onary heart disease risk than LDL-c, HDL-c and non-
HDL-c. A recent study found that non-HDL-c/HDL-c
was a better indicator than apolipoprotein B (ApoB)/
apolipoprotein A1 (ApoA1) and ApoB/LDL-c in identi-
fying MetS and insulin resistance [27,28]. However, fewstudies had evaluated the relationship between non-
HDL-c/HDL-c ratio and arterial stiffness.
The study compared the association between the rou-
tine lipids and the related ratios with baPWV for the
first time. However, the study has some limitations. First,
the experimental population was modest in size, and en-
tirely of Chinese origin, which may be limited in the
generalizability of the results. Second, since the study
was cross-sectional designed, no causal relationship be-
tween lipid profiles and the risk of arterial stiffness can
be drawn. Thus, we hope the findings can stimulate
more investigators.
In conclusion, the study provides the novel findings
that all the lipids and the ratios are significantly corre-
lated with baPWV. Non-HDL-c/HDL-c ratio performs
more effectively in identifying individuals at increased
arterial stiffness risk. As non-HDL-c/HDL-c is easy and
cost-effective obtained, it seems reasonable to propose
non-HDL-c/HDL-c as a surrogate indicator of arterial
stiffness in clinical practice.
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